This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;14(6):323.

doi: 10.1038/nrurol.2017.44. Epub 2017 Mar 21.

Prostate cancer: New model to test immunotherapy combinations

PMID: 28322260
DOI: 10.1038/nrurol.2017.44

Comment

Prostate cancer: New model to test immunotherapy combinations

Clemens Thoma. Nat Rev Urol. 2017 Jun.

. 2017 Jun;14(6):323.

doi: 10.1038/nrurol.2017.44. Epub 2017 Mar 21.

Author

PMID: 28322260
DOI: 10.1038/nrurol.2017.44

No abstract available

PubMed Disclaimer

Comment on

Effective combinatorial immunotherapy for castration-resistant prostate cancer.
Lu X, Horner JW, Paul E, Shang X, Troncoso P, Deng P, Jiang S, Chang Q, Spring DJ, Sharma P, Zebala JA, Maeda DY, Wang YA, DePinho RA. Lu X, et al. Nature. 2017 Mar 30;543(7647):728-732. doi: 10.1038/nature21676. Epub 2017 Mar 20. Nature. 2017. PMID: 28321130 Free PMC article.

References

1. Nature. 2017 Mar 30;543(7647):728-732 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information